• Home
  1. Home
  2. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial
Scientific article
OA Policy
English

Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial

ContributorsFinckh, Axelorcid; Mc Carthy, Geraldine M; Madigan, Anne; Van Linthoudt, Daniel; Weber, Marcel; Neto, David; Rappoport, Georges; Blumhardt, Sandra; Kyburz, Diego; Guerne, Pierre-André
Published inArthritis research & therapy, vol. 16, no. 5, 458
Publication date2014
Abstract

Calcium pyrophosphate deposition (CPPD) may cause severe arthropathy, major joint destruction and treatment options are limited. The aim of this study was to test the therapeutic efficacy of methotrexate (MTX) in chronic or recurrent CPPD arthropathy.

Affiliation entities
Research groups
Citation (ISO format)
FINCKH, Axel et al. Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial. In: Arthritis research & therapy, 2014, vol. 16, n° 5, p. 458. doi: 10.1186/s13075-014-0458-4
Main files (1)
Article (Published version)
accessLevelPublic CC BY
Identifiers
Journal ISSN1478-6354
710views
269downloads

Technical informations

Creation27/01/2015 15:26:00
First validation27/01/2015 15:26:00
Update24/01/2025 14:34:34
Status update24/01/2025 14:34:34
Last indexation24/01/2025 14:42:34
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack